{
    "organizations": [],
    "uuid": "2fda7285999c1a68fb473ff80d88d0781f93b437",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novabay-pharmaceuticals-announces/brief-novabay-pharmaceuticals-announces-preliminary-sales-for-q4-and-fy17-idUSASB0C00Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Novabay Pharmaceuticals Announces Preliminary Sales For Q4 And FY17",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Novabay Pharmaceuticals Inc:\n* - PRELIMINARY Q4 TOTAL SALES EXPECTED TO SLIGHTLY EXCEED $6 MILLION, UP 49% OVER Q4 OF 2016\n* NOVABAY PHARMACEUTICALS ANNOUNCES PRELIMINARY SALES FOR 2017 FOURTH QUARTER AND FULL YEAR\n* SEES FY 2017 REVENUE ABOUT $18 MILLION * SEES FY 2017 SALES UP 51 PERCENT * FY2017 REVENUE VIEW $17.9 MILLION -- THOMSON REUTERS I/B/E/S\n* Q4 REVENUE VIEW $6.0 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-08T19:55:00.000+02:00",
    "crawled": "2018-01-09T17:15:56.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "novabay",
        "pharmaceutical",
        "inc",
        "preliminary",
        "q4",
        "total",
        "sale",
        "expected",
        "slightly",
        "exceed",
        "million",
        "q4",
        "novabay",
        "pharmaceutical",
        "announces",
        "preliminary",
        "sale",
        "fourth",
        "quarter",
        "full",
        "year",
        "see",
        "fy",
        "revenue",
        "million",
        "see",
        "fy",
        "sale",
        "percent",
        "fy2017",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "q4",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}